ID   MBC647
AC   CVCL_UB97
DR   Wikidata; Q95985596
RX   CelloPub=CLPUB00793;
RX   PubMed=25960936;
CC   HLA typing: A*24:02,01:02; B*14:02,49:01; C*02:02,07:01; DQA1*01:02,01:02; DQB1*06:13,05:01; DRB1*15:01,01:02 (PubMed=25960936).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C5164; Breast metaplastic carcinoma
DI   ORDO; Orphanet_213531; Metaplastic carcinoma of the breast
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 6
//
RX   CelloPub=CLPUB00793;
RA   Foulkes W.D., Zhu J., Majewski J.;
RT   "Exploring the pathogenic and therapeutic implications of aberrant
RT   splicing in breast cancer.";
RL   (In misc. document) Report for award W81XWH-08-1-0402. Defense Technical Information Center document ADA561072; pp.1-21; DTIC; Fort Belvoir; USA (2011).
//
RX   PubMed=25960936; DOI=10.4161/21624011.2014.954893; PMCID=PMC4355981;
RA   Boegel S., Lower M., Bukur T., Sahin U., Castle J.C.;
RT   "A catalog of HLA type, HLA expression, and neo-epitope candidates in
RT   human cancer cell lines.";
RL   OncoImmunology 3:e954893.1-e954893.12(2014).
//